Thomas Anderson, Chief Commercial Strategy Officer at SAGE Therapeutics, holds 20.00K shares in Zevra Therapeutics (Ticker: ZVRA), holds 1.55K shares in SAGE Therapeutics (Ticker: SAGE). Most recently, Thomas Anderson Bought ― shares of Zevra Therapeutics on Jul 16, 2024 for an estimated value of 68.00K.
What is the percentage of profitable transactions made by Thomas Anderson?
The percentage of profitable transactions made by Thomas Anderson is 100%.
What is the average return per transaction made by Thomas Anderson?
The average return per transaction made by Thomas Anderson is 88.90%.
What stocks does Thomas Anderson hold?
Thomas Anderson holds: SAGE, ZVRA stocks.
What was Thomas Anderson’s latest transaction?
Thomas Anderson latest transaction was an Informative Buy of $68.00K.
What was Thomas Anderson's most profitable transaction?
Thomas Anderson’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
What is Thomas Anderson's role in SAGE Therapeutics?
Thomas Anderson's role in SAGE Therapeutics is Chief Commercial Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.